Skip to content

Other

Nalorphine (INN), its salts and ethers

CAS 62-67-9 Updated
3

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A prescription opioid antagonist (nalorphine) listed on EU Annex II of the Cosmetics Regulation — banned outright from cosmetics. Pharmaceutical-only molecule, never suitable for skin-care use.

Skin benefits

  • Primarily a processing aid

Known concerns

  • EU Annex II banned substance — prohibited in cosmetics
  • Pharmacologically active opioid antagonist
  • Not appropriate for any skin-contact cosmetic use
  • Pharmaceutical-only molecule with prescription-controlled status

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

3
4,5-DIAMINO-1-METHYLPYRAZOLE HCL
Other
 3
Acrylamide, unless regulated elsewhere in this Regulation
Other
 3
Alkanes, C2-3, if they contain > 0.1% w/w Butadiene
Other
 3
Alkanes, C3-4, if they contain > 0.1% w/w Butadiene
Other
 3
Amitrole (ISO)
Other
 3
Anthracene oil, acid ext.
Other
 3
Aromatic hydrocarbons, C6-10, C8-rich, if it contains > 0.1% w/w benzene
Other
 3
Aromatic hydrocarbons, C7-12, C8-rich, if it contains > 0.1% w/w benzene
Other

Check your shelf

Find Nalorphine (INN), its salts and ethers in your products.

Scan any cosmetic product with LuxSense to see if it contains Nalorphine (INN), its salts and ethers and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.